Tony, Great research. Well done. Is Neuronal Plasticity the common theme across many illnesses?. Is that the common denominator?
Does this lead to a wider range of disorders , you mention concussion, depression and General memory loss as in elderly and some posters like me.
If that is the correct line of thought then oral NNZ-2566 could be an everyday course of trea,ent for many older people who have mild memory loss. it would also be in every medical first aid kit for concussion. And how big is depression. Zoloft and Prozac are huge sellers.
So getting one FDA approval opens the door for off label prescriptions across so many diseases that have very little alternative.
Again, great research.
neu's rationale for targeting tbi and retts, page-3
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.54 |
Change
-0.490(2.88%) |
Mkt cap ! $2.106B | |||
| Open | High | Low | Value | Volume |
| $16.94 | $17.02 | $16.38 | $10.33M | 620.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5061 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.62 | 1284 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |